TDOC — Teladoc Health, Inc.

Teladoc Health (TDOC) Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Consolidated Revenue: $626 million, slightly down 2.2% year-over-year but above guidance midpoint.
• Adjusted EBITDA: $70 million, an 11.2% margin, reflecting disciplined execution.
• Net Loss per Share: $0.28, including a non-cash goodwill impairment charge of $0.07.
• Free Cash Flow: $68 million for Q3, totaling $113 million year-to-date.
• Cash Position: $726 million in cash and equivalents, up $47 million sequentially.
• Integrated Care Revenue: $390 million, up 1.5% year-over-year.
• BetterHelp Revenue: $236.9 million, with a significant portion from insurance revenue.

2. Strategic Updates and Business Highlights

• Integrated Care: Over 100 million people have access to Teladoc services. The company is enhancing its Prism care delivery platform to improve care management and outcomes.
• Chronic Care: Enrollment grew 4% sequentially, with new innovations planned for 2026.
• Mental Health: Double-digit growth in B2B mental health visits. The new employee assistance program, Wellbound, is gaining interest.
• Insurance Initiatives: BetterHelp is expanding its insurance offerings, now live in 7 states, with plans for broader rollout.
• International Growth: Integrated Care revenues grew 14% year-over-year on a constant currency basis, bolstered by the acquisition of Telecare in Australia.

3. Forward Guidance and Outlook

• 2025 Revenue Guidance: Expected to be between $2.510 billion and $2.539 billion.
• Adjusted EBITDA Guidance: Projected at $270 million to $287 million.
• Free Cash Flow Guidance: Anticipated in the range of $170 million to $185 million.
• BetterHelp Revenue Outlook: Expected decline of 8% to 9.2% year-over-year, primarily due to headwinds in the U.S. cash pay business.

4. Bad News, Challenges, or Points of Concern

• BetterHelp Segment: Average paying users declined 4% year-over-year, with challenges in the U.S. cash pay business due to increased competition and macroeconomic factors.
• Goodwill Impairment: The impairment charge reflects ongoing valuation challenges in the Integrated Care segment.
• Tariff Headwinds: Continued uncertainty regarding tariffs is expected to impact adjusted EBITDA by approximately $3 million.
• Competitive Pressures: Increased competition in the mental health space is affecting user acquisition and retention.

5. Notable Q&A Insights

• Sales Strategy for 2026: CEO Chuck Divita emphasized a shift towards value-based contracting, focusing on performance metrics that align with client expectations.
• BetterHelp Margins: Margins are under pressure as the company transitions from cash pay to insurance, but this shift is expected to lead to improved user retention and acquisition costs over time.
• Chronic Care Growth: The company is optimistic about future growth in chronic care, leveraging new innovations and clinical interventions.
• Insurance Rollout: Early metrics from the insurance initiative are promising, but the company is cautious about sharing specific conversion rates until more data is available.

This summary encapsulates the key takeaways from Teladoc's Q3 2025 earnings call, highlighting both the company's achievements and the challenges it faces moving forward.